Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters

Database
Language
Document Type
Year range
1.
Eur J Med Res ; 28(1): 86, 2023 Feb 20.
Article in English | MEDLINE | ID: covidwho-2260413

ABSTRACT

Exosomes are membranous vesicles with a 30 to 150 nm diameter secreted by mesenchymal stem/stromal cells (MSCs) and other cells, such as immune cells and cancer cells. Exosomes convey proteins, bioactive lipids, and genetic components to recipient cells, such as microRNAs (miRNAs). Consequently, they have been implicated in regulating intercellular communication mediators under physiological and pathological circumstances. Exosomes therapy as a cell-free approach bypasses many concerns regarding the therapeutic application of stem/stromal cells, including undesirable proliferation, heterogeneity, and immunogenic effects. Indeed, exosomes have become a promising strategy to treat human diseases, particularly bone- and joint-associated musculoskeletal disorders, because of their characteristics, such as potentiated stability in circulation, biocompatibility, low immunogenicity, and toxicity. In this light, a diversity of studies have indicated that inhibiting inflammation, inducing angiogenesis, provoking osteoblast and chondrocyte proliferation and migration, and negative regulation of matrix-degrading enzymes result in bone and cartilage recovery upon administration of MSCs-derived exosomes. Notwithstanding, insufficient quantity of isolated exosomes, lack of reliable potency test, and exosomes heterogeneity hurdle their application in clinics. Herein, we will deliver an outline respecting the advantages of MSCs-derived exosomes-based therapy in common bone- and joint-associated musculoskeletal disorders. Moreover, we will have a glimpse the underlying mechanism behind the MSCs-elicited therapeutic merits in these conditions.


Subject(s)
Exosomes , Joint Diseases , Mesenchymal Stem Cells , MicroRNAs , Musculoskeletal Diseases , Humans , Exosomes/genetics , Exosomes/metabolism , MicroRNAs/genetics , Musculoskeletal Diseases/therapy , Musculoskeletal Diseases/metabolism , Mesenchymal Stem Cells/physiology
2.
Nutrients ; 13(2)2021 Jan 20.
Article in English | MEDLINE | ID: covidwho-1094257

ABSTRACT

Worldwide, the burden of musculoskeletal disorders is increasing with great variations between-countries, which makes it difficult for policymakers to provide resources and adequate interventions in order to provide for their appropriate management [...].


Subject(s)
Diet , Dietary Supplements , Musculoskeletal Diseases , Nutrients , Animals , Biomarkers/analysis , Humans , Musculoskeletal Diseases/diagnosis , Musculoskeletal Diseases/metabolism , Musculoskeletal Diseases/physiopathology , Musculoskeletal Diseases/therapy , Nutritional Status
SELECTION OF CITATIONS
SEARCH DETAIL